Oruka Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Menlo Park, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oruka Therapeutics, Inc. has filed 1,498 SEC EDGAR filings since 12 Jun 1997

SEC filing history

Showing 351-375 of 936 matching filings.

Per page
25
Current page
15
DEFA14A File 000-22873

DEFA14A

Filing date
28 Oct 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-22873

DEF 14A

Filing date
28 Oct 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
07 Oct 2020
Reporting date
07 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Sep 2020
Reporting date
25 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Sep 2020
Reporting date
22 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Sep 2020
Reporting date
21 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
21 Sep 2020
Reporting date
21 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
31 Aug 2020
Reporting date
29 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
12 Aug 2020
Reporting date
12 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
05 Aug 2020
Reporting date
05 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-238067

424B5

Filing date
22 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
22 Jul 2020
Reporting date
22 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-238067

424B5

Filing date
14 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
14 Jul 2020
Reporting date
14 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-238067

424B5

Filing date
02 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
02 Jul 2020
Reporting date
02 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-51477

ACQUISITION OF BENEFICIAL OWNERSHIP

Filing date
10 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-238067

424B5

Filing date
03 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
03 Jun 2020
Reporting date
01 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-51477

SABBY 13G ABIO 6.01.20

Filing date
01 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
01 Jun 2020
Reporting date
01 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
28 May 2020
Reporting date
28 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-238067

EFFECT filing

Filing date
20 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
18 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .